Junji Inokoshi

1.8k total citations
48 papers, 1.4k citations indexed

About

Junji Inokoshi is a scholar working on Molecular Biology, Pharmacology and Biotechnology. According to data from OpenAlex, Junji Inokoshi has authored 48 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 21 papers in Pharmacology and 13 papers in Biotechnology. Recurrent topics in Junji Inokoshi's work include Microbial Natural Products and Biosynthesis (19 papers), Microbial Metabolism and Applications (8 papers) and HIV Research and Treatment (7 papers). Junji Inokoshi is often cited by papers focused on Microbial Natural Products and Biosynthesis (19 papers), Microbial Metabolism and Applications (8 papers) and HIV Research and Treatment (7 papers). Junji Inokoshi collaborates with scholars based in Japan, China and India. Junji Inokoshi's co-authors include Satoshi Ōmura, Haruo Tanaka, Hiroshi Tomoda, Kazuro Shiomi, Hideo Takeshima, Ryuji Uchida, Rokuro Masuma, YUZURU IWAI, Harumi Chiba and Hong Yang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and Scientific Reports.

In The Last Decade

Junji Inokoshi

48 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junji Inokoshi Japan 25 795 589 332 312 125 48 1.4k
Anne W. Dombrowski United States 26 1.0k 1.3× 793 1.3× 595 1.8× 266 0.9× 254 2.0× 50 2.1k
Enrico Selva Italy 20 927 1.2× 710 1.2× 342 1.0× 169 0.5× 140 1.1× 44 1.4k
Emilio Fernández Álvarez Spain 25 1.2k 1.5× 650 1.1× 173 0.5× 203 0.7× 282 2.3× 53 2.1k
Heather C. Losey United States 16 1.3k 1.7× 798 1.4× 542 1.6× 247 0.8× 86 0.7× 27 1.7k
Jason K. Sello United States 23 1.1k 1.4× 371 0.6× 592 1.8× 156 0.5× 121 1.0× 58 1.9k
Shuyi Si China 25 610 0.8× 437 0.7× 328 1.0× 166 0.5× 93 0.7× 87 1.3k
MAYUMI SHINOSE Japan 13 1.3k 1.6× 1.4k 2.3× 335 1.0× 373 1.2× 378 3.0× 18 2.0k
Peter Licari United States 21 1.2k 1.5× 480 0.8× 188 0.6× 204 0.7× 90 0.7× 44 1.6k
Philipp Krastel Switzerland 19 645 0.8× 511 0.9× 235 0.7× 147 0.5× 106 0.8× 32 1.1k
Amy M. Gehring United States 21 1.9k 2.4× 1.4k 2.4× 484 1.5× 386 1.2× 307 2.5× 23 2.7k

Countries citing papers authored by Junji Inokoshi

Since Specialization
Citations

This map shows the geographic impact of Junji Inokoshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junji Inokoshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junji Inokoshi more than expected).

Fields of papers citing papers by Junji Inokoshi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junji Inokoshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junji Inokoshi. The network helps show where Junji Inokoshi may publish in the future.

Co-authorship network of co-authors of Junji Inokoshi

This figure shows the co-authorship network connecting the top 25 collaborators of Junji Inokoshi. A scholar is included among the top collaborators of Junji Inokoshi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junji Inokoshi. Junji Inokoshi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Inokoshi, Junji, et al.. (2016). Inhibition of bacterial undecaprenyl pyrophosphate synthase by small fungal molecules. The Journal of Antibiotics. 69(11). 798–805. 11 indexed citations
2.
Inokoshi, Junji, et al.. (2016). Structure-Activity Analysis of Gram-positive Bacterium-producing Lasso Peptides with Anti-mycobacterial Activity. Scientific Reports. 6(1). 30375–30375. 20 indexed citations
3.
Inokoshi, Junji, Takashi Fukuda, Ryuji Uchida, et al.. (2013). Epi-trichosetin, a new undecaprenyl pyrophosphate synthase inhibitor, produced by Fusarium oxysporum FKI-4553. The Journal of Antibiotics. 66(9). 549–554. 28 indexed citations
4.
Inokoshi, Junji, et al.. (2012). Molecular cloning of the gene cluster for lariatin biosynthesis of Rhodococcus jostii K01-B0171. Applied Microbiology and Biotechnology. 95(2). 451–460. 45 indexed citations
5.
Takahashi, Atsushi, Junji Inokoshi, Atsuko Hachiya, et al.. (2011). The high mannose-type glycan binding lectin actinohivin: dimerization greatly improves anti-HIV activity. The Journal of Antibiotics. 64(8). 551–557. 12 indexed citations
6.
Inokoshi, Junji, et al.. (2009). Expression of two human acyl-CoA:diacylglycerol acyltransferase isozymes in yeast and selectivity of microbial inhibitors toward the isozymes. The Journal of Antibiotics. 62(1). 51–54. 24 indexed citations
7.
Inokoshi, Junji, et al.. (2009). Production of a new type of amidepsine with a sugar moiety by static fermentation of Humicola sp. FO-2942. The Journal of Antibiotics. 63(1). 9–16. 10 indexed citations
8.
Iwatsuki, Masato, Ryuji Uchida, Yoichi Takakusagi, et al.. (2007). Lariatins, Novel Anti-mycobacterial Peptides with a Lasso Structure, Produced by Rhodococcus jostii K01-B0171. The Journal of Antibiotics. 60(6). 357–363. 69 indexed citations
9.
10.
Chiba, Harumi, Junji Inokoshi, Keiichi Matsuzaki, et al.. (2001). Actinohivin, a Novel Anti-HIV Protein from an Actinomycete That Inhibits Syncytium Formation: Isolation, Characterization, and Biological Activities. Biochemical and Biophysical Research Communications. 282(2). 595–601. 50 indexed citations
11.
Inokoshi, Junji, Shiho Arima, Haruo Tanaka, et al.. (1999). Neuronal Differentiation of Neuro 2a Cells by Inhibitors of Cell Cycle Progression, Trichostatin A and Butyrolactone I. Biochemical and Biophysical Research Communications. 256(2). 372–376. 45 indexed citations
12.
Matsuzaki, Keiichi, et al.. (1998). New Brominated and Halogen-less Derivatives and Structure-activity Relationship of Azaphilones Inhibiting gp120-CD4 Binding.. The Journal of Antibiotics. 51(11). 1004–1011. 75 indexed citations
13.
Wang, Liru, et al.. (1998). Cloning of the gene encoding avermectin B 5-O-methyltransferase in avermectin-producing Streptomyces avermitilis. Gene. 206(2). 175–180. 21 indexed citations
14.
Uchida, Ryuji, Kazuro Shiomi, Junji Inokoshi, et al.. (1996). Andrastins A-C, New Protein Farnesyltransferase Inbibitors Produced by Penicillium sp. FO-3929. II. Structure Elucidation and Biosynthesis.. The Journal of Antibiotics. 49(5). 418–424. 61 indexed citations
15.
Shiomi, Kazuro, Hong Yang, Qi Xu, et al.. (1995). Phenopyrrozin, a New Radical Scavenger Produced by Penicillium sp. FO-2047.. The Journal of Antibiotics. 48(12). 1413–1418. 17 indexed citations
16.
Inokoshi, Junji, et al.. (1994). Cerulenin-resistant mutants of Saccharomyces cerevisiae with an altered fatty acid synthase gene. Molecular and General Genetics MGG. 244(1). 90–96. 74 indexed citations
17.
18.
Shiomi, Kazuro, Hong Yang, Junji Inokoshi, et al.. (1993). Pepticinnamins, new farnesyl-protein transferase inhibitors produced by an actinomycete. II. Structural elucidation of pepticinnamin E.. The Journal of Antibiotics. 46(2). 229–234. 62 indexed citations
19.
Inokoshi, Junji, et al.. (1989). Production of hepatitis B virus surface antigen containing pre-S1 and pre-S2 domains by Chinese hamster ovary cells. Archives of Virology. 106(1-2). 151–158. 1 indexed citations
20.
Takeshima, Hideo, Mitsuo Namiki, Junji Inokoshi, et al.. (1989). Stable expression of hepatitis B virus genome in a primate kidney cell. Archives of Virology. 109(1-2). 35–49. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne W. Dombrowski Breakdown of academic impact, for papers by Enrico Selva Breakdown of academic impact, for papers by Emilio Fernández Álvarez Breakdown of academic impact, for papers by Heather C. Losey Breakdown of academic impact, for papers by Jason K. Sello Breakdown of academic impact, for papers by Shuyi Si Breakdown of academic impact, for papers by MAYUMI SHINOSE Breakdown of academic impact, for papers by Peter Licari Breakdown of academic impact, for papers by Philipp Krastel Breakdown of academic impact, for papers by Amy M. Gehring
Rankless by CCL
2026